Rare diseases
Investigational molecules
Locations
Back to France951 clinical trials in Nantes, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Preventing Infections in ICU Patients with Interferon Gamma and Sodium Chloride
FranceStudy on Anti-CD20 Therapy and Drug Combination for Patients with Relapsing-Remitting Multiple Sclerosis
FranceStudy on the Effectiveness and Safety of Sonrotoclax and Zanubrutinib for Adults with Relapsed or Refractory Mantle Cell Lymphoma
FranceStudy on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
FranceStudy of dexamethasone effectiveness in reducing complications and mortality in patients with severe burns
FranceStudy on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome
FranceStudy on Rituximab for Patients with Rheumatoid Arthritis: Comparing 200 mg and 1g Doses for Maintenance Treatment
FranceStudy Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide
FranceStudy Comparing Duvelisib with Gemcitabine or Bendamustine for Patients with Relapsed or Resistant T Cell Lymphoma Originating from T Follicular Helper Cells
FranceStudy on the Effects of Darolutamide and Drug Combination for Patients with Metastatic Hormone-Naïve Prostate Cancer
FranceStudy on Obinutuzumab for Patients with Relapsing Granulomatosis with Polyangiitis
FranceStudy Comparing Elranatamab and Lenalidomide with Daratumumab and Lenalidomide for Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients
FranceThe busiest research cities in the country
What the registry says about research in the country
Advanced research focusing on multiple myeloma, leukemia, and various lymphomas. Studies are evaluating novel treatment combinations and therapeutic approaches for blood cancers.
Innovative trials exploring combinations of targeted therapies and immunotherapies to improve patient outcomes.
Comprehensive studies on preventive measures against viral infections, including trials for vaccines targeting CMV, yellow fever, and mpox.
Focus on developing and evaluating new vaccine formulations and delivery methods.
Research investigating treatments for inflammatory bowel diseases and multiple sclerosis, including innovative approaches like fecal microbiota transplantation.
Exploring novel therapeutic options and treatment de-escalation strategies.
Studies addressing postoperative care and management of severe conditions in intensive care settings, including burns and immune suppression.
Evaluating new approaches to improve patient comfort and outcomes in critical care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
